113 related articles for article (PubMed ID: 16474204)
1. Benidipine, a calcium channel blocker, regulates proliferation and phenotype of vascular smooth muscle cells.
Arakawa E; Hasegawa K
J Pharmacol Sci; 2006 Feb; 100(2):149-56. PubMed ID: 16474204
[TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative effects of benidipine hydrochloride in porcine cultured vascular smooth muscle cells and in rats subjected to balloon catheter-induced endothelial denudation.
Ide S; Kondoh M; Satoh H; Karasawa A
Biol Pharm Bull; 1994 May; 17(5):627-31. PubMed ID: 7920421
[TBL] [Abstract][Full Text] [Related]
3. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
4. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling.
Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL
Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813
[TBL] [Abstract][Full Text] [Related]
5. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Nakamura T; Obata JE; Onitsuka M; Shimada Y; Yoshida Y; Kawachi H; Shimizu F
Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
[TBL] [Abstract][Full Text] [Related]
6. Benidipine, an anti-hypertensive drug, relaxes mouse airway smooth muscle.
Yang Y; Chen W; Wen N; Cai C; Liu QH; Shen J
Life Sci; 2019 Jun; 227():74-81. PubMed ID: 31002920
[TBL] [Abstract][Full Text] [Related]
7. Slow onset of and recovery from Ca blocking action of benidipine in rat aorta and portal vein.
Gotoh Y; Kumadani S; Kawai T; Imaizumi Y; Watanabe M
Jpn J Pharmacol; 1989 Sep; 51(1):37-45. PubMed ID: 2478742
[TBL] [Abstract][Full Text] [Related]
8. Effects of benidipine, a dihydropyridine-Ca2+ channel blocker, on expression of cytokine-induced adhesion molecules and chemoattractants in human aortic endothelial cells.
Matsubara M; Hasegawa K
Eur J Pharmacol; 2004 Sep; 498(1-3):303-14. PubMed ID: 15364009
[TBL] [Abstract][Full Text] [Related]
9. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
[TBL] [Abstract][Full Text] [Related]
10. Benidipine, a dihydropyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells.
Matsubara M; Hasegawa K
Atherosclerosis; 2005 Jan; 178(1):57-66. PubMed ID: 15585201
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cGMP-dependent protein kinase reverses phenotypic modulation of vascular smooth muscle cells.
Dey NB; Foley KF; Lincoln TM; Dostmann WR
J Cardiovasc Pharmacol; 2005 May; 45(5):404-13. PubMed ID: 15821435
[TBL] [Abstract][Full Text] [Related]
12. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
[TBL] [Abstract][Full Text] [Related]
13. The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta.
Takayama M; Yao K; Wada M
J Biomed Sci; 2009 Jun; 16(1):57. PubMed ID: 19558657
[TBL] [Abstract][Full Text] [Related]
14. A potent 1,4-dihydropyridine L-type calcium channel blocker, benidipine, promotes osteoblast differentiation.
Nishiya Y; Kosaka N; Uchii M; Sugimoto S
Calcif Tissue Int; 2002 Jan; 70(1):30-9. PubMed ID: 11907705
[TBL] [Abstract][Full Text] [Related]
15. Benidipine suppresses in situ proliferation of leukocytes and slows the progression of renal fibrosis in rat kidneys with advanced chronic renal failure.
Kazama I; Baba A; Matsubara M; Endo Y; Toyama H; Ejima Y
Nephron Exp Nephrol; 2014; 128(1-2):67-79. PubMed ID: 25358915
[TBL] [Abstract][Full Text] [Related]
16. L-ascorbic acid stimulates expression of smooth muscle-specific markers in smooth muscle cells both in vitro and in vivo.
Arakawa E; Hasegawa K; Irie J; Ide S; Ushiki J; Yamaguchi K; Oda S; Matsuda Y
J Cardiovasc Pharmacol; 2003 Dec; 42(6):745-51. PubMed ID: 14639096
[TBL] [Abstract][Full Text] [Related]
17. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mitogen-mediated proliferation of rat vascular smooth muscle cells by labedipinedilol-A through PKC and ERK 1/2 pathway.
Liou SF; Yeh JL; Liang JC; Chiu CC; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2004 Nov; 44(5):539-51. PubMed ID: 15505490
[TBL] [Abstract][Full Text] [Related]
19. Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells.
Chen CN; Li YS; Yeh YT; Lee PL; Usami S; Chien S; Chiu JJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2665-70. PubMed ID: 16477012
[TBL] [Abstract][Full Text] [Related]
20. Characterization of transcriptional and posttranscriptional properties of native and cultured phenotypically modulated vascular smooth muscle cells.
Huggins CL; Povstyan OV; Harhun MI
Cell Tissue Res; 2013 May; 352(2):265-75. PubMed ID: 23263463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
